lobbying_activities: 3389021

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3389021	d078306d-c7de-4948-85a2-926c90992f14	Q2	BRAVO GROUP	296293	PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA	2025	second_quarter	PHA	Biopharmaceutical issues including: social and economic, value of the biopharmaceutical sector, patient access and safety issues, drug importation, life science innovation, and job impact.	HOUSE OF REPRESENTATIVES,SENATE	40000		0	0	2025-07-17T14:29:53-04:00